-
Original Article
-
Korean J Med. 2006;71(3):285-292.
- 원저:혈액투석 환자에서 빈혈에 대한 L-carnitine 투여의 효과
-
오지영,
-
- Effects of L-carnitine supplementation on anemia in patients undergoing hemodialysis
-
Ji Young Oh, Seung Jung Kim
-
고려대학교 의과대학 내과학교실
-
- Abstract
- Background : There are many causes of carnitine depletion in hemodialysis patients; carnitine
insufficiency may contribute to renal anemia. In the current study, we examined whether L-carnitine
supplementation could improve renal anemia. In addition, we examined whether proinflammatory
cytokines such as tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) contribute to
patient response to L-carnitine supplementation.
Methods
: We studied 40 hemodialysis patients; they showed decreased free carnitine levels and
were selected to receive L-carnitine intravenously after each hemodialysis session for six months.
Before and after treatment, we measured the level of hemoglobin, iron parameters, TNF-α, IFN-γ
and weekly doses of recombinant human erythropoietin (rHuEPO).
Results
: There was no difference in hemoglobin level, however the doses of weekly rHuEPO
were decreased significantly after L-carnitine treatment (3735.29±1728.76 U/week Vs 3000.02±
1858.64 U/week, p=0.02). The serum levels of transferrin, total iron binding capacity and ferritin were
significantly increased after L-carnitine treatment. Transferrin saturation, serum albumin, parathyroid
hormone and C-reactive protein were not changed. In addition, TNF-α and IFN-γ were not
changed either.
Conclusions
: A reduction in rHuEPO was achieved during L-carnitine treatment while
maintaining a constant hemoglobin level, which was not related to proinflammatory cytokines;
however, it may be attributed to increased serum transferrin levels.(Korean J Med 71:285-292, 2006)
Key Words : Carnitine, Anemia, Proinflammatory cytokine, Transferrin
Keywords :
